Agoracom Blog Home
Archive for the ‘Namaste Technologies Inc.’ Category
INTERVIEW: Namaste $N.ca $NXTTF Discusses Strategic Private-Label Software and Patient Referral Agreements with Aurora Cannabis $ACB.ca $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 4:33 PM on Tuesday, January 2nd, 2018
Aurora $ACB.ca and Namaste $N.ca $NXTTF to Complete Strategic Private-Label Software and Patient Referral Agreements $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 7:19 AM on Tuesday, January 2nd, 2018
- Namaste will provide CanvasRx with a customized, CanvasRx-branded version of NamasteMD
- Namaste will provide CanvasRx with a two-year exclusivity period for the private label version of NamsteMD.com in Canada
EDMONTONÂ and VANCOUVER, Jan. 2, 2018 – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. (“Namaste”) (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced the signing of a binding term sheet towards a final Private-Label Software Agreement (“Private Label Agreement”), whereby Namaste will provide Aurora’s wholly-owned subsidiary, CanvasRx Inc. (“CanvasRx”) with a customized version of Namaste’s patient acquisition tool, NamasteMD.com (“NamasteMD”), Â as well as desktop and mobile applications for Google Android and Apple iOS platforms. The companies have 30 days to complete a final agreement.
Private Label Agreement
NamasteMD is an online telemedicine platform for patient consultation and registration, bringing together Namaste`s tested technology platform, including certain proprietary authentication technologies, as well as consultation, education and medical document issuance processes. Under the terms of the Private Label Agreement:
- Namaste will provide CanvasRx with a customized, CanvasRx-branded version of NamasteMD
- Namaste will provide CanvasRx with a two-year exclusivity period for the private label version of NamsteMD.com in Canada
- Namaste will initially provide the application for both the Google Android and Apple iOS platforms
- CanvasRx will require their own doctors and/or nurse practitioners to operate the platform
- Commercial terms of the agreement are not disclosed
- In consideration of Aurora’s assistance for the future optimization of NamasteMD, Namaste has issued Aurora 500,000 stock options, exercisable at $3.35 per common share for 48 months, vesting quarterly over 12 months.
Support Services Agreement
In addition, the companies have also signed a non-binding, non-exclusive Letter of Intent to complete a final Consultation & Support Services Agreement (“Consultation Agreement”), whereby Namaste will provide patient referral services to Aurora, where applicable under Canada’s Access to Cannabis for Medical Purposes (“ACMPR”) regulations. Under the terms of the Consultation Agreement:
- Namaste shall provide certain patient-focused education and strain selection services, as well as assistance in preparing the requisite paperwork (Medical Documentation) for registering patients with Aurora
- The Agreement is non-exclusive for a one-year term
- Namaste shall provide the services under the agreement on preferential terms to Aurora
- Commercial terms of the Consultation Agreement are not disclosed
The agreements further strengthen the strategic ties between the two companies, who already collaborate on eCommerce (sale of Namaste-sourced, curated selection of vaporizers through Aurora website, utilizing Namaste’s technology platform), and the distribution of BC Northern Lights products. Once completed, the new agreements will provide Namaste with recurring revenues through the private label platform, while Aurora will be the only licensed producer able to offer Namaste`s streamlined online patient acquisition platform under its own (CanvasRx) brand.
Management Commentary
“NamasteMD provides an innovative and efficient extension to our industry-leading in-person cannabis counseling and education services provided through CanvasRx,” said Terry Booth, CEO. “The new platform will enable us to extend our industry leading patient care to areas where we currently have no physical presence. This will allow us to leverage the strength of both the CanvasRx and Aurora brands, without having to commit to substantial investments in brick and mortar facilities. Namaste is a trusted partner with whom we already successfully collaborate on two promising initiatives, and we look forward to extending our partnership based on innovation and customer care excellence.”
Sean Dollinger, President and CEO of Namaste added, “We are thrilled to have Aurora, the industry’s most innovative and dynamic Licensed Producer, as our preferred strategic partner. Our drive to innovate meets the cannabis industry`s need for reliable technological solutions to improve operational efficiencies and expand the customer experience. We are very proud to be aligned with Aurora’s team, and look forward to executing on our ongoing collaboration.”
About Aurora
Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as “Aurora Mountain”, a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal’s West Island, and is currently constructing an 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, as well as is completing a fourth facility in Lachute, Quebec through its wholly owned subsidiary Aurora Larssen Projects Ltd.
In addition, the Company holds approximately 17.23% of the issued shares in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 22.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany. The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens. Aurora’s common shares trade on the TSX under the symbol “ACB”.
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany, and has opened new supply channels into emerging markets, including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
On behalf of the Boards of Directors
Terry Booth
Sean Dollinger
Chief Executive Officer
Chief Executive Officer
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Aurora and Namaste are under no obligation, and expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX or CSE, nor their Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange and CSE) accept responsibility for the adequacy or accuracy of this release.
Namaste $N.ca Announces Wholesale Supply LOI With Israel-Based BRLEV $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 9:42 AM on Wednesday, December 27th, 2017
- Signed a Letter of Intent (“LOIâ€) with BRLEV AGRICULTURAL CROPS LTD
- BRLEV will supply CannMart with high quality medical cannabis, to be imported by CannMart from Israel and offered in the Company’s online marketplace
VANCOUVER, British Columbia, Dec. 27, 2017 — Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N)(FRANKFURT:M5BQ)(OTCMKTS:NXTTF) is pleased to announce that it has signed a Letter of Intent (“LOIâ€) with BRLEV AGRICULTURAL CROPS LTD. (“BRLEVâ€), through its wholly owned subsidiary, Cannmart Inc. (“CannMartâ€), whereby BRLEV will supply CannMart with high quality medical cannabis, to be imported by CannMart from Israel and offered in the Company’s online marketplace. BRLEV is Israel’s largest licensed producer of medical cannabis, with over 40 years of experience in commercial agricultural production and export. BRLEV will work with Namaste to export medical cannabis to the Canadian market, which will fall under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPRâ€) guidelines. The LOI and the proposed medical cannabis supply agreement (“Supply Agreementâ€) highlight Namaste’s intentions of becoming Canada’s leading online retailer for medical cannabis products, by focusing on importation of high quality medical cannabis from industry-leading countries like Israel. Namaste believes that the demand for imported cannabis and the opportunity it presents has been largely overlooked. This deal solidifies Namaste’s commitment in seeking the best cannabis products in global markets and offering them to Canadian cannabis users.
Terms of the LOI:
- Namaste will submit purchase orders to BRLEV for medical cannabis.
- Namaste will provide 50% payment against each purchase order once the goods arrive at the airport and have been tested by a third-party laboratory facility. The balance of payment will be due within 30 days from the shipment date.
- Product cost to Namaste will be determined as 30% of Namaste’s retail price.
- Namaste will be responsible for shipping and import costs.
- Namaste’s product branding and naming conventions for each strain will adhere to Israeli government requirements where applicable.
- Namaste will mark each customer package with BRLEV’s name and logo.
The LOI and proposed Supply Agreement reinforce Namaste’s effort to provide imported medical cannabis products to its patients by offering the largest variety of products from domestic and international producers. BRLEV boasts one of the largest production facilities in Israel and is a strong partner for Namaste. Namaste believes that BRLEV’s existing license and infrastructure will be suited to accommodate the Company’s expected demand for high quality Israeli grown medical cannabis. Namaste is highly focused on cannabis importation for its CannMart facility and specifically on sourcing from the Israeli market. This partnership will allow Namaste to offer greater value for its patients by allowing CannMart to provide a larger offering in comparison with domestic ACMPR licensed producers. The Company expects to see strong demand for imported cannabis products and looks forward to a growing relationship with BRLEV and its management team.
Management Commentary
Asaf Bardichev, President and CEO of BRLEV comments: “BRLEV is very excited to announce the signing of this LOI. We see Namaste as a central and leading figure in the growing Canadian retail market and see this as a great opportunity for collaboration. We believe that the partnership with Namaste that we are beginning now can be a long and lasting one. It will be one that strengthens Namaste, BRLEV, and the Canadian medical cannabis market.”
Sean Dollinger, President and CEO of Namaste comments: “While the Canadian market continues to be a leader with regards to the production of high quality cannabis, Namaste remains of the opinion that Canadian consumers will demand other high-quality products from markets abroad. Through our partnership with BRLEV, Namaste fully intends to meet that demand. This transaction represents the first of many partnerships by which Namaste intends to create the largest and most diverse marketplace for Canadian cannabis consumers. We are very pleased to have signed this LOI and are looking forward to working with the BRLEV Group. Namaste believes this represents a strong partnership based on BRLEV’s credentials and experience in cultivation and agricultural export. The BRLEV management team has exceptional talents for cultivation and production of the highest quality medical cannabis in the Israeli market. We look forward to working with BRLEV and their team in creating the most diverse offering of medical cannabis in the Canadian online retail marketplace.â€
About BRLEV
The BRLEV Group manages cannabis based medicine production from mother plants to final product. The group is fully licensed in all aspects of cannabis cultivation and processing as well as in the manufacturing of cannabis based medication in Israel. With an impressive lineup of high-end facilities and over 40 years of experience in agriculture the BRLEV group meets the highest industry standards including GMP, Global Gap and Tesco. Working closely with the leading Israeli research bodies in plant genetics, virus and pest control, cannabis processing and active substance extraction, BRLEV uses state of the art methods and knowledge in cannabis cultivation and processing. The BRLEV group has also secured a cannabis trading license which enables the group to start exporting its products overseas as soon as export regulations are in place.
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
On behalf of the Board of Directors
“Sean Dollingerâ€
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
INTERVIEW: Namaste $N.ca Discusses Fulfillment Agreement With Greenlane $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 2:09 PM on Friday, December 22nd, 2017
- Greenlane will provide order fulfillment for direct website and wholesale sales
- Greenlane will provide all services related to inventory owned and maintained by Greenlane, including pulling, packing and shipping orders.
- Greenlane will make a one-time purchase of inventory specified by Namaste based on 360-day payment terms, to ensure adequate inventory levels
Sean Dollinger, President and CEO of Namaste comments: “The signing of this agreement may very well be one of the most important initiatives Namaste has implemented to date, and may be the final piece of the puzzle in helping Namaste achieve profitability. The agreement itself represent months of negotiations which has culminated with an amazing partnership with easily the most influential business-to-business distributor in the space…â€
Namaste $N.ca Signs Fulfillment Agreement With Greenlane $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 8:20 AM on Friday, December 22nd, 2017
- Announced that its wholly owned subsidiary Cannmart Inc. has signed a Fulfilment Services Agreement with Greenlane Canada
- Greenlane will fulfill orders for all products set forth in Greenlane’s product offering as well as products which are marketed and sold under brands controlled by Namaste and other third-party products as specified by Namaste
VANCOUVER, British Columbia, Dec. 22, 2017 — Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N)(OTCQB:NXTTF)(FRANKFURT:M5BQ) is pleased to announce that its wholly owned subsidiary Cannmart Inc. (“Cannmartâ€) has signed a Fulfilment Services Agreement (the “Agreementâ€) with Greenlane Canada (“Greenlaneâ€) whereby Greenlane will provide exclusive order fulfilment and warranty services for Namaste’s Canadian websites. Under the terms of the Agreement, Greenlane will fulfill orders for all products set forth in Greenlane’s product offering as well as products which are marketed and sold under brands controlled by Namaste and other third-party products as specified by Namaste. The Agreement represents a strategic decision to further align the Company with the industry’s leading business-to-business distributor, while Namaste will benefit through a significant reduction of inventory and operational expenses, bringing the company closer to profitability. Since inception, Namaste has maintained a strong working relationship with Greenlane and believes that this Agreement is accretive in nature. In addition, it is believed this Agreement will set the framework for Namaste to collaborate with Greenlane on future opportunities in areas related to the distribution of cannabis packaging products and pre-filled cartridges for medical cannabis, to be sold in Canada through Namaste’s wholly owned subsidiary Cannmart.
Key Terms of the Agreement
- Greenlane will provide order fulfillment for direct website and wholesale sales.
- Greenlane will provide all services related to inventory owned and maintained by Greenlane, including pulling, packing and shipping orders.
- Greenlane will make a one-time purchase of inventory specified by Namaste based on 360-day payment terms, to ensure adequate inventory levels.
- Greenlane shall be responsible for warehousing of Namaste’s inventory including the costs of rent, fixtures, insurance and shrinkage.
- Services will be rendered in a manner consistent with Greenlane’s Standard Operating Procedures (“SOPâ€) for its own customers as it relates to:
- Order accuracy
- Order processing time
- On-time shipments
- Packages damaged in transit
- Greenlane will provide Namaste with access to new products added to its catalogue.
- Greenlane will provide technical services as it relates to repairs and warranty services for Namaste’s customers.
The Agreement with Greenlane represents a key component of Namaste’s strategy moving forward, and is expected to have an immediate impact on cash-flow. The partnership further demonstrates Namaste’s commitment to focusing its resources towards the expansion of its global network, in an attempt to solidify its place in the Canadian market as the dominant player.
Additionally, Namaste remains diligent on launching medical cannabis sales in Canada, as it looks to first validate its platform and then expand into additional markets abroad. Namaste believes these combined initiatives will serve as a stepping stone in helping Namaste achieve its goal of reaching profitability, as it looks to capitalize on strategic partnerships with its peers.
Management Commentary
Aaron LoCasio, Greenlane’s CEO comments: “Sean and the Namaste team have built an exceptional company that we are proud to work alongside. This agreement further aligns our respective organizations and allows us each to focus on our core competencies. Greenlane looks forward to working with the Namaste team as we each embark on this next phase of growth.â€
Sean Dollinger, President and CEO of Namaste comments: “The signing of this agreement may very well be one of the most important initiatives Namaste has implemented to date, and may be the final piece of the puzzle in helping Namaste achieve profitability. The agreement itself represent months of negotiations which has culminated with an amazing partnership with easily the most influential business-to-business distributor in the space. Our decision to partner with Greenlane was directly correlated to their amazing range of products, and proven track record in securing exclusive distribution rights for the hottest new products ahead of the competition. In addition, we believe Namaste will capture market share in the extremely exciting pre-filled hardware space by leveraging Greenlane’s exclusive access to closed system products from the leading brands. This competitive edge will be instrumental in allowing Namaste the ability to offer our customers the latest products within the Canadian market.â€
About GreenlaneÂ
Greenlane is the leading distributor of premium brands in the burgeoning head shop, smoke shop, and dispensary channels. Since 2005, Greenlane has worked diligently to build a reputation as the industry leader by meeting the needs of our customers, suppliers, and the end-users of the products we distribute. The company has achieved this by offering the most innovative products at competitive prices, providing white glove customer service, and processing orders quickly with unparalleled, highly efficient operations and logistics. During this time, Greenlane has grown to over 150 employees with operations in 7 cities across the United States and Canada, including 5 highly automated distribution centers, and continues to grow by finding ways to better serve the needs of its customers and suppliers.
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
On behalf of the Board of Directors
“Sean Dollingerâ€
Chief Executive Officer
Direct: +1 (786) 389 9771
Email:Â [email protected]
Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
World Health Group: Pot’s #CBD Has Health Benefits #Marijuana $MCOA $N.ca $TBP.ca $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 4:25 PM on Tuesday, December 19th, 2017
- Compound found in the cannabis plant is not harmful, has health benefits, and does not have abuse potential, experts at the World Health Organization say.
- WHO’s Expert Committee on Drug Dependence focused on cannabidiol, or CBD, one of the naturally occurring cannabinoids found in cannabis plants
After reviewing evidence from animal and human studies, the committee concludes that “In humans, CBD exhibits no effects indicative of any abuse or dependence potential.”
Slideshow: Medical Marijuana
1/10
What Is Medical Marijuana?
Medical marijuana is any part of the marijuana plant that you use to treat health problems. People use it to get relief from their symptoms, not to try to get high.
Most marijuana that’s sold legally as medicine has the same ingredients as the kind that people use for pleasure. But some medical marijuana is specially grown to have less of the chemicals that cause feelings of euphoria.
The experts also say that CBD might be able to treat epilepsy (where most research has focused), although results are mixed. Other conditions it might treat are Alzheimer’s disease, Parkinson’s, anxiety, depression, and other maladies. CBD may ease inflammation, provide antioxidants, and relieve pain.
Based on its research, the committee concluded that current information does not call for scheduling of the drug. In the U.S., CBD is a Schedule 1 controlled substance. These are defined as drugs with no medical use and likely to be abused.
Twenty-nine states and Washington, D.C., have legalized the use of marijuana for recreational or medicinal purposes. Other states, including Georgia, have legalized the possession of CBD to treat specific disorders.
It remains a federal crime, however, to have or sell any form of marijuana, including CBD. Despite those federal regulations, CBD is an ingredient in popular products sold over the counter as oils, extracts, supplements, and gum to treat many ailments.
CBD usually is given as a capsule or dissolved in liquid to be taken orally, under the tongue, or as a nasal spray. CBD does not produce the high that another cannabinoid — tetrahydrocannabinol (THC) — does, experts say. In fact, CBD appears to have effects opposite of THC.
The WHO announcement drew a positive response from marijuana advocates and criticism from those who don’t want it to be legal.
The experts produced the report in November, while the WHO announced its conclusions this week. In May, the committee will study cannabis and cannabis-related substances more fully.
Other major studies have shown marijuana and its products can relieve pain, nausea related to cancer treatment, and multiple sclerosis-related muscle spasms. But using cannabis has well-known short-term and long-term health effects, such as learning and coordination problems.
Because federal law makes it a crime to have marijuana and CBD, researchers must pass strict government scrutiny just to study its usefulness.
DEA View of CBD
The conclusion of the WHO flies in the face of the view of the U.S. Drug Enforcement Administration (DEA). It says that CBD must be treated the same as THC and other cannabinoids from a cannabis plant, and it should remain a Schedule I drug.
NORML Response
Marijuana advocates applauded the WHO’s conclusion. “It was terrific to see WHO acknowledge what other scientific research has already stated,” says Justin Strekal, political director of the National Organization for the Reform of Marijuana Laws (NORML).
In an email statement, he adds: “While we are pleased to see the WHO finally acknowledge that absurdity of international restrictions, the continued domestic classification and criminalization of cannabidiol as a Schedule I controlled substance is out of step with both available science and common sense. It is yet another example of the U.S. government placing ideology over evidence when it comes to issues related to the cannabis plant.â€
CALM Response
Scott Chipman, Southern California chairman of Citizens Against Legalizing Marijuana (CALM), took issue with the report.
“We need to maintain a strict scientific perspective and protocols when it comes to new drugs,” he says. “We need double-blind studies related to marijuana and all components, research on the harms versus the benefits, identification of the side effects and specific ailments identified through these studies — even for CBD,” he says.
He says some ongoing drug studies of CBD do show promise in treating seizure disorders, but he also sees potential problems with the drugs, along with concerns about contamination and other potential harms with over-the-counter products.
Source: https://www.webmd.com/a-to-z-guides/news/20171215/world-health-group-pots-cbd-has-health-benefits
INTERVIEW: Namaste $N.ca Continues Hitting Milestones Faster Than Any Other Small Cap Company We Know, WATCH NOW! $ATT.ca $ABCN.ca $ACG.ca $ACB
Posted by
at 9:57 AM on Friday, December 8th, 2017
We have never interviewed a client more than we’ve interviewed Namaste Technologies – and with good reason. The Company just continues to hit milestones faster than any other small cap company we know.
This can be attributed to the fact Namaste has evolved into a tech powerhouse within the medical cannabis delivery systems industry – GLOBALLY. More than just lip service, the company’s e-commerce sites are operating in 26 countries and all of them will soon be powered by Artificial Intelligence. Namaste also has 5 distribution hubs located around the world, making them the world’s largest E-Commerce B2C vaporizer company.
Does that story sound familiar? Because to us it sounds a whole lot like the beginnings of Amazon. Namaste was founded in a garage and focused on just one product. Today, it spans the globe and growing like wildfire through acquisitions, joint ventures and partnerships because EVERYONE wants to work with Namaste. Namaste is on it’s way to “Amazoning” the entire industry – and they have the Amazon blue print to follow.
The Company’s latest milestone? Surpassing $2M in monthly revenue. It’s a major one and puts Namaste into rarified air. It’s sequential 69% growth and annual 146% growth tell us the story is only getting started.
Grab a coffee, strap yourself in and watch President and CEO, Sean Dollinger, show you a glimpse into the future.
Namaste $N.ca Announces November Record Sales of C$2.2M $AERO $CBDS $CGRW $APH.ca $GBLX
Posted by
at 7:54 AM on Thursday, December 7th, 2017
- Record breaking sales for the month of November 2017 of C$2.2M
- 69% month-on-month increase
- 146% year-on year increase
VANCOUVER, B.C., Dec. 07, 2017 — Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N) (OTCQB:NXTTF) (FRANKFURT:M5BQ) is pleased to announce record breaking sales for the month of November 2017, as reported by the Company (including shipping revenues after discounts and refunds) of C$2.2M, equating to a 69% month-on-month increase and a 146% year-on year increase, representing Namaste’s highest month of revenue in the Company’s history. In addition to achieving record breaking sales, the month of November has been transformational for Namaste. The Company’s exponential growth further validates that many initiatives which management has implemented over the past year have been overwhelmingly successful. Namaste has grown and consolidated the cannabis ancillary product industry to become the largest business-to-consumer retailer for vaporizers and smoking products globally. Namaste, through its wholly owned subsidiary, Cannmart Inc. (“CannMartâ€), and through the launch of NamasteMD Inc. (“NamasteMDâ€), believes that the Company is positioned to become a global leader for medical cannabis sales.
The table below displays a breakdown of Namaste’s gross revenue by sales channel. Total un-audited net revenue as reported by the Company (including shipping revenues after discounts and refunds) were C$2,221,340 in November 2017 compared to C$1,313,653 in October 2017, a 69% increase due to higher revenues from all revenue channels. Year on year revenues increased 146% in November 2017 compared with November 2016. In addition to the overwhelming success of Namaste’s Black Friday and Cyber Monday sales campaigns, the Company has also seen strong revenue growth in other sales channels.
The table below outlines gross sales of Namaste’s major sites and includes site traffic, conversion rates, total number of orders per site and average online basket price. By comparison, our conversion rates continue to improve month over month and ahead of schedule, which has been attributed to the implementation of our machine learning technology and SEO initiatives. The Company expects to see those trends continue as it collects data and continues to customize the platform to improve efficiencies and achieve growth.
While the Company is pleased with record breaking sales and organic revenue growth, Namaste anticipates seeing further growth once CannMart’s sales license for medical cannabis distribution is obtained and through the launch of NamasteMD. Namaste’s management team believes that once these two initiatives are in place, the Company will play a crucial role in the Canadian medical cannabis industry through online retail sales.
From the outset, management has been focused on creating a seamless customer experience that allows cannabis patients the ability to use Namaste’s platform throughout the entire medicinal cannabis process. Through the Company’s innovative telemedicine application, NamasteMD, patients will not only be able to obtain their medical cannabis documentation but will also have access to highly trained professionals who will consult, educate and support all patients.  NamasteMD and O Cannabis We Stand on Guard for Thee Corporation, which will act as Namaste’s partner for patient acquisitions, will play an integral role in ensuring Namaste’s patients are well cared for. The final link will be achieved through CannMart and will allow Namaste the ability to offer patients a wide range of medical cannabis products.
Management believes that with the infrastructure it has strategically assembled, the Company will become Canada’s leading online retailer for medical cannabis. Namaste has demonstrated its ability to succeed in the niche market of vaporizers, and believe our successes will translate over to medical cannabis products once our sales license is obtained. This will pave the way for Namaste to become a global leader and one of the first and only “One Stop Shops†in the medical cannabis space.
Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “Namaste’s goal from the outset was to create a platform that provides medicinal cannabis users with all the products and services required to make well-informed decisions. We believe we have achieved that by providing our users with access to highly trained professionals that can help guide them throughout the process and by offering superior products at competitive prices in the market.
Our continued growth in sales proves the e-commerce infrastructure we have created is highly successful and we fully intend on duplicating those successes with regards to medical cannabis products, which we believe represents an even greater opportunity. We believe we now have all the pieces in place to fully exploit the medical cannabis markets in Canada and abroad. In addition to seeing significant growth in sales, management is also pleased to report that the Company has sufficient cash resources to continue its strategic growth plan. Namaste’s management teaming is working towards reducing operating overhead in order to further enhance its positive working capital position.â€
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
On behalf of the Board of Directors
“Sean Dollingerâ€
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
Aphria $APH.ca to supply medical marijuana to Shoppers Drug Mart $N.ca $TBP.ca $MCOA
Posted by
at 1:19 PM on Tuesday, December 5th, 2017
Namaste $N.ca Announces Non-Binding Letter of Intent With O Cannabis Clinic for Management Services $ATT.ca $ABCN.ca $ACG.ca $ACB
Posted by
at 8:44 AM on Tuesday, December 5th, 2017
- LOI represents a major milestone for Namaste in the expansion of its platform into medical cannabis sales using the Company’s innovative telemedicine application, and will provide an incredibly efficient platform for patient consultations and medical documentation issuance
VANCOUVER, British Columbia, Dec. 05, 2017 – Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N) (OTCQB:NXTTF) (FRANKFURT:M5BQ) is pleased to announce that it has signed an non-binding letter of intent (“LOIâ€) with O Cannabis We Stand On Guard For Thee (“O Cannabisâ€) under which O Cannabis will provide patient consultation services to Namaste’s wholly owned subsidiary, NamasteMD Inc. (“NamasteMDâ€). Pursuant to the LOI, O Cannabis will provide management services to NamasteMD that will include patient consultations, education, strain recommendations and medical document issuance to qualified patients under the guidance of nurse practitioners. In addition to these services, O Cannabis will also be offering a select range of Namaste’s vaporizer hardware in their online platform.
This LOI represents a major milestone for Namaste in the expansion of its platform into medical cannabis sales using the Company’s innovative telemedicine application, and will provide an incredibly efficient platform for patient consultations and medical documentation issuance. NamasteMD customers will have the ability to connect to Namaste’s e-commerce platform through Namaste’s wholly owned subsidiary, Cannmart Inc. (“CannMartâ€), which will provide patients with an online marketplace for medical cannabis products, including strains sourced from both domestic and international licensed producers. CannMart is a late stage applicant for a “Sales Only License†under the Canadian Access to Cannabis for Medical Purposes Regulations (“ACMPRâ€) program. Namaste’s goal is to become Canada’s leading medical cannabis online retailer by leveraging its existing consumer base, along with utilizing its advanced expertise in e-commerce. In doing so, Namaste believes it can successfully convert and on-board patients at an accelerated growth rate and offer the best quality of care for its patients. Namaste believes that with its aggressive growth strategy and the implementation of NamasteMD, it will be able to accumulate a minimum of 18,200 patients within the first calendar year of operations. This figure is based on Namaste’s current site traffic of 1,000 unique visitors per day with a 5% conversion rate, which would generate 350 patients per week. Namaste expects each patient acquisition to cost on average $60 per patient, based on the terms of the LOI, which is currently lower than any industry standard for medical patients.
About O Cannabis
O Cannabis offers affordable medical cannabis telemedicine appointments to patients across Canada, allowing timely access to quality medicine in remote and under-serviced regions; from Yukon to Newfoundland and everywhere in between. O Cannabis has built a name for themselves by offering unparalleled patient education and industry leading follow up care. O Cannabis patients report their appreciation for the easy and fun telemedicine experience, O Cannabis’ streamlined approach to medical document issuance and the exceptional care patients receive at each step of their medical cannabis journey.
Terms of the LOI
Under the terms of the LOI, the O Cannabis management team will be responsible for the general operation of NamasteMD’s platform and will provide the following services:
- Patient Qualification
- Patient Onboarding
- Education
- Recommendations (strains and dosages)
- Follow-up Care
- Medical Documents
- Self-titration Training
- Maintaining 75% patient retention rates
In return for these services, Namaste will pay O Cannabis as follows:
- CAD $60 for each patient approval, being a patient consultation resulting in the issuance of a prescription for medical cannabis
- 50% of the net profit for “platinum†packages, as will be outlined in the definitive agreement
- 5% of the gross revenue collected for patients where medical cannabis is sourced from local licensed producers
- 10% of the gross revenue collected for patients where medical cannabis is sourced from international licensed producers
- 15% of the gross revenue collected through the sale of Namaste’s vaporizers and cannabis ancillary products, which O Cannabis will add to its website
- The issuance of 15,000 common share stock options to the O Cannabis management team
Closing of the proposed definitive agreement will be contingent on negotiation and execution of definitive documentation containing standard terms, representations and warranties and indemnities for an agreement of this nature, approval of the agreement by each party’s respective board of directors and shareholders, if applicable, and by the Canadian Securities Exchange, if applicable.
NamasteMD is an innovative application that connects patients with medical practitioners through a secure video conference call and incorporates industry-leading facial recognition technology, including instant age and identity verification using data feeds linked to federal databases. The O Cannabis management team is a highly trained group of medical professionals that offer industry leading care for their patients. Through the NamasteMD platform, patients will be offered a variety of packages that will include both free and paid options. Once a patient receives a medical document, they will have access to purchase directly from CannMart’s medical cannabis marketplace. The Company expects full launch of NamasteMD, including the app for both Apple and Android platforms, to be in operation and accepting patients as soon as December 15, 2017.
Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “With many of these exciting initiatives now in place, Namaste believes it has successfully created the necessary infrastructure to become a leader in medical cannabis sales in Canada. In addition to Canada, Namaste believes this infrastructure can be easily implemented into other progressive jurisdictions where medical cannabis legislation is in place, and fully intends on exploiting all markets where Namaste has existing operations and market presence. Our goal now is to focus heavily on patient acquisition through our existing database of consumers and to accelerate growth through our e-commerce platform.â€
About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
On behalf of the Board of Directors
“Sean Dollingerâ€
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk
FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.